New journal coming to touchIMMUNOLOGY soon!
touchREVIEWS in RMD
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Select a Section…
1
Article
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
International experts from the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) have recently partnered to produce the much-anticipated classification criteria for antiphospholipid syndrome (APS), which were published in Arthritis & Rheumatology in August 2023.1 Prior to the publication of the new ACR/EULAR APS classification criteria, research studies used the Sapporo criteria, […]
Mark CompleteCompleted
BookmarkBookmarked
Chronic back pain (CBP), defined as back pain lasting for 3 months or more, is the most common pain condition globally.1 Greater healthcare utilization, productivity limitations and poor quality of life have immediate and long-term impacts on patients and the healthcare ...
Mark CompleteCompleted
BookmarkBookmarked
Welcome to the latest edition of touchREVIEWS in RMD! We’re excited to share a dynamic collection of articles that highlight the evolving landscape of rheumatic and musculoskeletal diseases (RMDs). We open the issue by delving into a series of ...
Mark CompleteCompleted
BookmarkBookmarked
This editorial outlines a clinical approach to patients with periodic inflammation of unknown origin despite initial rational and targeted investigation. The focus of the editorial is on the recognition and diagnosis of systemic autoinflammatory diseases (SAIDs). Although rare, SAIDs are ...
Mark CompleteCompleted
BookmarkBookmarked
The global burden of disease is heavily impacted by the increased prevalence of chronic inflammatory rheumatic diseases (CIRDs [rheumatoid arthritis (RA), spondyloarthritis (SpA), connective tissue diseases (CTDs) crystal arthropathies and polyarticular osteoarthritis (OA)]), which are prevalent chronic non-communicable diseases associated ...
Mark CompleteCompleted
BookmarkBookmarked
Systemic lupus erythematosus (SLE) predominantly affects females and is characterized by multisystem involvement.1,2Â Despite advancements in therapeutics, patients with SLE still experience poor health-related quality of life (HRQoL).3Â Systemic sclerosis (SSc) is characterized by vasculopathy and fibrosis of the skin ...
Mark CompleteCompleted
BookmarkBookmarked
Biologics are medications derived from biological sources used to treat several immune-mediated inflammatory diseases. These medications interfere with autoimmune processes by inhibiting specific molecular or cellular targets. They are highly effective medications, mostly used in cases of moderate-to-severe disease activity. ...
Mark CompleteCompleted
BookmarkBookmarked
The preamble of the World Health Organization's constitution defines health as “a state of complete physical, mental and social wellbeing, and not merely the absence of disease or infirmity".1 An optimal state of health is considered a fundamental human right. ...
Mark CompleteCompleted
BookmarkBookmarked
Systemic rheumatic diseases (RDs) commonly arise during a woman’s reproductive years and may have implications for family planning and pregnancy. Among the RDs, systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are classically associated with an increased risk of ...
Mark CompleteCompleted
BookmarkBookmarked
Many environmental factors have been associated with the development of autoimmunity.1 Infections, for example, can cause reactive arthritis by triggering a (genetically) predisposed immune system.2 Smoking, in a similar, but arguably different, way, can trigger the production of autoantibodies by ...
Mark CompleteCompleted
BookmarkBookmarked
Reducing the risk of rheumatic and musculoskeletal disease (RMD) is crucial to prevent associated chronic disease burden. However, the process is complex because the aetiopathological factors contributing to disease onset are not entirely understood. Healthy eating based on the Mediterranean ...
Mark CompleteCompleted
BookmarkBookmarked
Living with inflammatory arthritis (IA) can pose multiple challenges throughout the lives of patients, as well as to their families and friends. Despite major advances in available treatments for inflammatory arthritides, such as rheumatoid arthritis and spondyloarthritis, there remains an ...
Mark CompleteCompleted
BookmarkBookmarked
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) includes several distinct clinical entities: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) and renal-limited vasculitis. What all these diseases have in common is the presence of serum autoantibodies, ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
